middle.news
Island Pharmaceuticals Advances Galidesivir with FDA Orphan Status and Ebola Outbreak Use
9:47am on Thursday 30th of July, 2026 AEST
•
Pharmaceuticals
Read Story
Island Pharmaceuticals Advances Galidesivir with FDA Orphan Status and Ebola Outbreak Use
9:47am on Thursday 30th of July, 2026 AEST
Key Points
GMP manufacturing commenced for Galidesivir
Expanded CRADA with USAMRIID finalises dose optimisation study
FDA grants Orphan Drug Designation for Marburg virus prophylaxis
Regulatory approvals secured for compassionate use in Uganda Ebola outbreak
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE